Literature DB >> 1486893

Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.

K Vogt1, J Hermann, U Blume, H Gollnick, H Hahn, U F Haustein, C E Orfanos.   

Abstract

The antibacterial activity of the topical quinolone OPC-7251 against bacteria commonly found in acne vulgaris was tested in vitro by an agar dilution method. The MIC50 was 0.25 mg/l for Propionibacterium acnes, 0.125 mg/l for Propionibacterium granulosum, 0.03 mg/l for Staphylococcus aureus and 0.06 mg/l for coagulase-negative staphylococci. Compared with seven other antibiotics tested (ciprofloxacin, penicillin, erythromycin, tetracycline, clindamycin, fusidic acid and gentamicin), OPC-7251 had potent activity against both propionibacteria and staphylococci and the lowest incidence of resistant strains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486893     DOI: 10.1007/bf01962381

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

Review 1.  Pathogenesis and pathogenesis related treatment of acne.

Authors:  H P Gollnick; C C Zouboulis; H Akamatsu; I Kurokawa; A Schulte
Journal:  J Dermatol       Date:  1991-09       Impact factor: 4.005

2.  The microbial colonization of inflamed acne vulgaris lesions.

Authors:  J P Leeming; K T Holland; W J Cuncliffe
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

Review 3.  The use of antibiotics in acne therapy: oral or topical administration?

Authors:  E A Eady; K T Holland; W J Cunliffe
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

4.  Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition.

Authors:  W L Lee; A R Shalita; K Suntharalingam; S M Fikrig
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.

Authors:  E A Eady; J H Cove; K T Holland; W J Cunliffe
Journal:  Br J Dermatol       Date:  1989-07       Impact factor: 9.302

6.  Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base.

Authors:  I Kurokawa; H Akamatsu; S Nishijima; Y Asada; S Kawabata
Journal:  J Am Acad Dermatol       Date:  1991-10       Impact factor: 11.527

  6 in total
  4 in total

1.  Activity of newer fluoroquinolones in vitro against gram-positive bacteria.

Authors:  G M Eliopoulos
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Transdermal penetration of topical drugs used in the treatment of acne.

Authors:  Andrea Krautheim; Harald Gollnick
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Glycosides of Nadifloxacin-Synthesis and Antibacterial Activities against Methicillin-Resistant Staphylococcus aureus.

Authors:  Mark Hutchins; Richard A Bovill; Peter J Stephens; John A Brazier; Helen M I Osborn
Journal:  Molecules       Date:  2022-02-23       Impact factor: 4.411

4.  Efficacy and safety of nadifloxacin for bacterial skin infections: results from clinical and post-marketing studies.

Authors:  Varsha Narayanan; Salman Motlekar; Ganesh Kadhe; Seema Bhagat
Journal:  Dermatol Ther (Heidelb)       Date:  2014-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.